When GLP-1 weight-loss drugs from Novo Nordisk (NVO) and Eli Lilly (LLY) first became popular, investors feared it would affect...
weightloss
Aspen reported higher earnings as Africa’s largest drug maker benefits from a restructuring of its manufacturing operations and expands its...
Check out what's clicking on FoxBusiness.com. Novo Nordisk sued Eli Lilly on Tuesday, accusing its rival of misleading consumers by...
It's been about five years since the U.S. Food and Drug Administration approved Wegovy for chronic weight management, but semaglutide,...
You can also listen to this podcast on iono.fm here. JEREMY MAGGS: The global boom in weight-loss and diabetes drugs...
Eli Lilly, the pharmaceutical giant, secured an important victory in the intensifying war against diabetes and obesity.Earlier this month, the...
Wegovy costs $1,350 a month without insurance, and Zepbound runs $1,086. If you're on Medicare, you've either been paying those...